Anticoagulación y antiagregación en Dermatología

Khalifeh, 2006, The management of patients on anticoagulants prior to cutaneous surgery: case report of a thromboembolic complication, review of the literature, and evidence-based recommendations, Plast Reconstr Surg, 118, 110, 10.1097/01.prs.0000221114.01290.85 Schanbacher, 2000, Postoperative stroke after stopping warfarin for cutaneous surgery, Dermatol Surg, 26, 785, 10.1046/j.1524-4725.2000.00079.x Kovich, 2002, Perioperative management of anticoagulants and platelet inhibitors for cutaneous surgery: a survey of current practice, Dermatol Surg, 28, 513 Alcalay, 2004, Controversies in perioperative management of blood thinners in dermatologic surgery: continue or discontinue?, Dermatol Surg, 30, 1091 Hirsh, 2001, Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range, Chest, 119, 8S, 10.1378/chest.119.1_suppl.8S Kearon, 1997, Management of anticoagulation before and after elective surgery, N Engl J Med, 22, 506 Alcalay, 2001, Cutaneous surgery in patients receiving warfarin therapy, Dermatol Surg, 27, 756 Otley, 1996, Complications of cutaneous surgery in patients who are taking warfarin, aspirin, or nonsteroidal anti-inflammatory drugs, Arch Dermatol, 132, 161, 10.1001/archderm.1996.03890260063009 Kargi, 2002, Complications of minor cutaneous surgery in patients under anticoagulant treatment, Aesth Plast Surg, 26, 483, 10.1007/s00266-002-2055-1 Billingsley, 1997, Intraoperative and postoperative bleeding problems in patients taking warfarin, aspirin, and nonsteroidal anti-inflammatory agents: a prospective study, Dermatol Surg, 23, 381, 10.1111/j.1524-4725.1997.tb00065.x Ah-Weng, 2003, Perioperative monitoring of warfarina in cutaneous surgery, Br J Dermatol, 149, 386, 10.1046/j.1365-2133.2003.05506.x Dixon, 2007, Bleeding complications in skin cancer surgery are associated with warfarin but not aspirin therapy, Br J Surg, 94, 1356, 10.1002/bjs.5864 Blasdale, 2008, Postoperative bleeding and warfarin, Br J Dermatol, 158, 522, 10.1111/j.1365-2133.2007.08419.x Heit, 2001, Perioperative management of the chronically anticoagulated patient, J Thromb Thrombolysis, 77, 81, 10.1023/A:1012746729537 Kincaid, 2003, Effects of perioperative enoxaparin versus unfractioned heparin on bleeding indices in patients undergoing coronary artery by-pass grafting, Ann Thorac Surg, 76, 124, 10.1016/S0003-4975(03)00190-5 Medalion, 2003, Preoperative use of enoxaparin is not a risk factor for postoperative bleeding after coronary artery bypass surgery, J Thorac Cardiovasc Surg, 126, 1875, 10.1016/S0022-5223(03)01324-2 Stables, 2002, Management of patients taking anticoagulant, aspirin, non-steroidal anti-inflammatory and other anti-platelet drugs undergoing dermatological surgery, Clin Exp Dermatol, 27, 432, 10.1046/j.1365-2230.2002.01097.x Buvanendran, 2003, Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial, JAMA, 290, 2411, 10.1001/jama.290.18.2411 Bartlett, 2001, Does aspirin affect outcome of minor cutaneous surgery?, Br J Plast Surg, 54, 214 Lawrence, 1994, Effect of aspirin and nonsteroidal anti-inflammatory drug therapy on bleeding complications in dermatological surgery patients, J Am Acad Dermatol, 31, 988, 10.1016/S0190-9622(94)70269-1 Quinn, 1999, Ticlopidine and clopidogrel, Circulation, 100, 1667, 10.1161/01.CIR.100.15.1667 Valeyrie-Allanore, 2007, Drug-induced skin, nail and hair disorders, Drug Saf, 30, 1011, 10.2165/00002018-200730110-00003 Litt, 2004, Drug eruption reference manual, 123 Birchner, 2006, Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options, Allergy, 61, 1432, 10.1111/j.1398-9995.2006.01227.x Valdivielso, 2004, Cutaneous necrosis induced by acenocumarol, J Eur Acad Dermatol Venereol, 18, 211, 10.1111/j.1468-3083.2004.00735.x Essex, 1998, Late-onset warfarin-induced skin necrosis: case report and review of the literarure, Am J Hematol, 57, 233, 10.1002/(SICI)1096-8652(199803)57:3<233::AID-AJH10>3.0.CO;2-B Talmadge, 2003, Purple toes syndrome associated with warfarin therapy in a patient with antiphospholipid syndrome, Pharmacotherapy, 23, 674, 10.1592/phco.23.5.674.32200 Soisson, 1994, An unusual cutaneous reaction to anticoagulant therapy, Mil Med, 159, 252, 10.1093/milmed/159.3.252 Kruis-de Vries, 1989, Maculopapular rash due to coumarin derivatives, Dermatologica, 178, 109, 10.1159/000248403 Anthony, 1993, Unusual cutaneous adverse reaction to warfarin therapy, South Med J, 86, 1413, 10.1097/00007611-199312000-00022 Komericki, 2007, Acute generalized exanthematous pustulosis from dalteparin, J Am Acad Dermatol, 57, 718, 10.1016/j.jaad.2007.05.025 Mureebe, 2002, Heparin-induced trombocytopenia: pathophysiology and management, Vasc Endovascular Surg, 36, 163, 10.1177/153857440203600302 Toll, 2005, Low-molecular-weight heparin-induced skin necrosis: a potential association with pre-existent hypercoagulable states, Int J Dermatol, 44, 964, 10.1111/j.1365-4632.2004.02326.x Warkentin, 1999, Heparin-induced trombocytopenia: a ten-year retrospective, Annu Rev Med, 50, 129, 10.1146/annurev.med.50.1.129 Jappe, 1999, Allergy to heparin, heparinoids, and recombinant hirudin. Diagnostic and therapeutic alternatives, Hautartzt, 50, 406, 10.1007/s001050050932 CAPRIE Steering Comittee, 1996, A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3 Zakarija, 2004, Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent re searchers, pharmaceutical suppliers, and the Food and Drug Administration, Stroke, 35, 533, 10.1161/01.STR.0000109253.66918.5E Meissner, 2006, Suberythrodermic pustular psoriasis induced by clopidogrel, Br J Dermatol, 155, 627, 10.1111/j.1365-2133.2006.07380.x Dogra, 2003, Clopidogrel bisulphate-induced photosensitive lichenois eruption: first report, Br J Dermatol, 148, 609, 10.1046/j.1365-2133.2003.05209_17.x Comert, 2005, Clopidogrel-induced hypersensitivity syndrome associated with febrile pancytopenia, Int J Dermatol, 44, 882, 10.1111/j.1365-4632.2005.02366b.x Doogue, 2005, Clopidogrel hypersensitivity syndrome with rash, fever, and neutropenia, Mayo Clinic Proc, 80, 1368, 10.4065/80.10.1368 Pintor, 2001, Vasculitis leucocitoclástica en relación con ticlopidina, Rev Esp Cardiol, 54, 114, 10.1016/S0300-8932(01)76272-0 Whetsel, 1999, Rash in patients receiving ticlopidine after coronary stent placement, Pharmacotherapy, 19, 228, 10.1592/phco.19.3.228.30916 Fukushima, 2007, Incidence of side-effects of ticlopidine after sirolimus-eluting stent implantation, Circ J, 617, 10.1253/circj.71.617 García, 2001, Fixed drug eruption from ticlopidine, with positive lesional patch test, Contact Dermatitis, 44, 40, 10.1034/j.1600-0536.2001.440107-7.x His, 1999, Toxic erythroderma due to ticlopidine, N Engl J Med, 340, 1212, 10.1056/NEJM199904153401514 Yosipovitz, 1999, Adverse cutaneous reactions to ticlopidine in patients with coronary stents, J Am Acad Dermatol, 41, 473, 10.1016/S0190-9622(99)70124-6 Kurokawa, 2005, Lichen planus-type drug eruption resulting from tyclopidine, Int J Dermatol, 44, 437, 10.1111/j.1365-4632.2005.02266.x Fabris, 1999, A paradoxical side-effect of antiaggregating treatment with ticlopidine: the Moschowitz syndrome, Haematologica, 84, 760 Bennet, 1998, Thrombotic thrombocytopenic purpura associated with ticlopidine: a review of 60 cases, Ann Intern Med, 128, 541, 10.7326/0003-4819-128-7-199804010-00004 Thachil, 2008, Management of surgical patients receiving anticoagulation and antiplatelet agents, Br J Surg, 95, 1437, 10.1002/bjs.6381